elizabeth worthey

elizabeth worthey

orcid

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 May 2013 in Scientific Reports
Verified
Journal Article
Open access
PDF file
JSJulie Sullivan
Julie Sullivan
KKKalpana Karra
Kalpana Karra
SMSierra A. T. Moxon
Sierra A. T. Moxon
AVAndrew Vallejos
Andrew Vallejos
HMHowie Motenko
Howie Motenko
GMGos Micklem
Gos Micklem
Model organisms are widely used for understanding basic biology and have significantly contributed to the study of human disease. In recent years, genomic analysis has provided extensive evidence of widespread conservation of gene sequence and function amongst eukaryotes, allowing insights from model organisms to help decipher gene function in a wider range of species. The InterMOD consortium is developing an infrastructure based around the InterMine data warehouse system to integrate genomic and functional data from a number of key model organisms, leading the way to improved cross-species research. So far including budding yeast, nematode worm, fruit fly, zebrafish, rat and mouse, the project has set up data warehouses, synchronized data models and created analysis tools and links between data from different species. The project unites a number of major model organism databases, improving both the consistency and accessibility of comparative research, to the benefit of the wider scientific community.

4 August 2023 in medRxiv
Verified
Preprint
Open access
PDF file
SSSarah L. Stenton
Sarah L. Stenton
MOMelanie O’leary
Melanie O’leary
GLGabrielle Lemire
Gabrielle Lemire
GVGrace E. VanNoy
Grace E. VanNoy
SDStephanie DiTroia
Stephanie DiTroia
AOAnne O’donnell-Luria
Anne O’donnell-Luria
Background: A major obstacle faced by rare disease families is obtaining a genetic diagnosis. The average “diagnostic odyssey” lasts over five years, and causal variants are identified in under 50%. The Rare Genomes Project (RGP) is a direct-to-participant research study on the utility of genome sequencing (GS) for diagnosis and gene discovery. Families are consented for sharing of sequence and phenotype data with researchers, allowing development of a Critical Assessment of Genome Interpretation (CAGI) community challenge, placing variant prioritization models head-to-head in a real-life clinical diagnostic setting. Methods: Predictors were provided a dataset of phenotype terms and variant calls from GS of 175 RGP individuals (65 families), including 35 solved training set families, with causal variants specified, and 30 test set families (14 solved, 16 unsolved). The challenge tasked teams with identifying the causal variants in as many test set families as possible. Ranked variant predictions were submitted with estimated probability of causal relationship (EPCR) values. Model performance was determined by two metrics, a weighted score based on rank position of true positive causal variants and maximum F-measure, based on precision and recall of causal variants across EPCR thresholds. Results: Sixteen teams submitted predictions from 52 models, some with manual review incorporated. Top performing teams recalled the causal variants in up to 13 of 14 solved families by prioritizing high quality variant calls that were rare, predicted deleterious, segregating correctly, and consistent with reported phenotype. In unsolved families, newly discovered diagnostic variants were returned to two families following confirmatory RNA sequencing, and two prioritized novel disease gene candidates were entered into Matchmaker Exchange. In one example, RNA sequencing demonstrated aberrant splicing due to a deep intronic indel in ASNS , identified in trans with a frameshift variant, in an unsolved proband with phenotype overlap with asparagine synthetase deficiency. Conclusions: By objective assessment of variant predictions, we provide insights into current state-of-the-art algorithms and platforms for genome sequencing analysis for rare disease diagnosis and explore areas for future optimization. Identification of diagnostic variants in unsolved families promotes synergy between researchers with clinical and computational expertise as a means of advancing the field of clinical genome interpretation.

5 January 2023 in PLOS Computational Biology
Verified
Journal Article
Open access
PDF file
VOVishal Oza
Vishal Oza
JWJordan H Whitlock
Jordan H Whitlock
EWElizabeth J Wilk
Elizabeth J Wilk
AUAngelina Uno-Antonison
Angelina Uno-Antonison
BWBrandon Wilk
Brandon Wilk
BLBrittany Lasseigne
Brittany Lasseigne
With an increasing amount of biological data available publicly, there is a need for a guide on how to successfully download and use this data. The 10 simple rules for using public biological data are: (1) use public data purposefully in your research; (2) evaluate data for your use case; (3) check data reuse requirements and embargoes; (4) be aware of ethics for data reuse; (5) plan for data storage and compute requirements; (6) know what you are downloading; (7) download programmatically and verify integrity; (8) properly cite data; (9) make reprocessed data and models Findable, Accessible, Interoperable, and Reusable (FAIR) and share; and (10) make pipelines and code FAIR and share. These rules are intended as a guide for researchers wanting to make use of available data and to increase data reuse and reproducibility.

11 April 2025 in bioRxiv
Verified
Preprint
Open access
PDF file
ATAustyn Trull
Austyn Trull
NCnf-core community
nf-core community
EWelizabeth worthey
elizabeth worthey
LILara Ianov
Lara Ianov
Recent advancements in long-read single-cell RNA sequencing (scRNA-seq) have facilitated the quantification of full-length transcripts and isoforms at the single-cell level. Historically, long-read data would need to be complemented with short-read single-cell data in order to overcome the higher sequencing errors to correctly identify cellular barcodes and unique molecular identifiers. Improvements in Oxford Nanopore sequencing, and development of novel computational methods have removed this requirement. Though these methods now exist, the limited availability of modular and portable workflows remains a challenge. Here we present, nf-core/scnanoseq, a secondary analysis pipeline for long-read single-cell and single-nuclei RNA that delivers gene and transcript-level quantification. The scnanoseq pipeline is implemented using Nextflow and is built upon the nf-core framework, enabling portability across computational environments, scalability and reproducibility of results across pipeline runs. The nf-core/scnanoseq workflow follows best practices for analyzing single-cell and single-nuclei data, performing barcode detection and correction, genome and transcriptome read alignment, unique molecular identifier deduplication, gene and transcript quantification, and extensive quality control reporting. AVAILABILITY OF DATA AND MATERIALS nf-core/scnanoseq is available at https://github.com/nf-core/scnanoseq under the MIT License and the documentation is available at https://nf-co.re/scnanoseq. The downstream analytical code for validation analysis is available at https://github.com/U-BDS/scnanoseq_analysis and all dataset sources have been disclosed under the methods section for each respective dataset.

23 October 2023 in Journal of Open Source Software
Verified
Journal Article
Open access
PDF file
MGManavalan Gajapathy
Manavalan Gajapathy
BWBrandon M. Wilk
Brandon M. Wilk
EWelizabeth worthey
elizabeth worthey
Quality Control (QC) of human genome sequencing and exome sequencing data is necessary to ensure they are of sufficient quality for downstream analyses. While several QC tools are available to measure quality parameters at various levels post-sequencing, their output needs to be reviewed and interpreted in a very manual and time-consuming process. Such manual review is a major challenge towards standardization and consistency, as the process can be subjective depending on the reviewer. To address these difficulties, we have developed QuaC, which implements, integrates, and standardizes QC best practices at our Center. It performs three major steps: (1) runs several QC tools using data produced by the read alignment (BAM) and small variant calling (VCF) as input and optionally accepts QC output for raw sequencing reads (FASTQ); (2) executes QuaC-Watch to perform QC checkup based on the expected thresholds for quality metrics; and (3) aggregates QC metrics produced by all the QC tools as well as QuaC-Watch results into single, self-contained MultiQC report, both at the per-sample and across-project levels. This report provides aggregate summaries for all samples within a project/cohort for efficient comprehensive review while still allowing for granular review down to individual metrics for a single sample. Finally, we have developed a "Sample QC review system" schema to standardize QC reviewer's logging of results and simplify downstream users' interpretation of the reviewers finding.

6 December 2023 in bioRxiv
Verified
Preprint
Open access
PDF file
MMMehri Monavarian
Mehri Monavarian
EPEmily Faith Page
Emily Faith Page
RRResha Rajkarnikar
Resha Rajkarnikar
AKAsha Kumari
Asha Kumari
LMLiz Quintero Macias
Liz Quintero Macias
KMKarthikeyan Mythreye
Karthikeyan Mythreye
Anoikis resistance or evasion of cell death triggered by matrix detachment is a hallmark of cancer cell survival and metastasis. We show that repeated exposure to suspension stress followed by recovery under attached conditions leads to development of anoikis resistance. The acquisition of anoikis resistance is associated with enhanced invasion, chemoresistance, and immune evasion in vitro and distant metastasis in vivo. This acquired anoikis resistance is not genetic, persisting for a finite duration without detachment stress, but is sensitive to CDK8/19 Mediator kinase inhibition that can also reverse anoikis resistance. Transcriptomic analysis reveals that CDK8/19 kinase inhibition induces bidirectional transcriptional changes in both sensitive and resistant cells, disrupting the balanced reprogramming required for anoikis adaptation and resistance by reversing some resistance associated pathways and enhancing others. Both anoikis resistance and in vivo metastatic growth of ovarian cancers are sensitive to CDK8/19 inhibition, thereby providing a therapeutic opportunity to both prevent and suppress ovarian cancer metastasis.